+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Forecast 2024-2030- Product Image
Global Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Forecast 2024-2030- Product Image
Sale

Global Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666357
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Urinary Tract Infection Testing Market size was estimated at USD 571.59 million in 2023, USD 630.24 million in 2024, and is expected to grow at a CAGR of 10.74% to reach USD 1,167.86 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Urinary Tract Infection Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urinary Tract Infection Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthcare GmbH, T2 Biosystems, Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Urinary Tract Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Cystitis
    • Pyelonephritis
    • Urethritis
    • Vaginitis
  • Test
    • Cystoscopy Urinary Tract Infection Testing
    • Kidney & Bladder Ultrasound Urinary Tract Infection Testing
    • Laboratory Test
    • Non-Laboratory Test
    • Nuclear Scans Urinary Tract Infection Testing
    • Susceptibility Urinary Tract Infection Testing
    • Urinalysis Urinary Tract Infection Testing
    • Urine Culture Urinary Tract Infection Testing
    • Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing
  • End-Use
    • Accountable Care Organizations
    • General Practitioners
    • Hospital Emergency Departments
    • Hospital Laboratories
    • Reference Laboratories
    • Urgent Care
    • Urogynecologists
    • Urologists
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Urinary Tract Infection Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urinary Tract Infection Testing Market?
  3. What are the technology trends and regulatory frameworks in the Urinary Tract Infection Testing Market?
  4. What is the market share of the leading vendors in the Urinary Tract Infection Testing Market?
  5. Which modes and strategic moves are suitable for entering the Urinary Tract Infection Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Urinary Tract Infection Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of urinary tract infections among geriartic and women
5.1.1.2. Prevalence of diabetes and kidney stones
5.1.1.3. Favorable investments by the government to increase rapid diagnostics
5.1.2. Restraints
5.1.2.1. Product recall and lack of awareness among the people
5.1.3. Opportunities
5.1.3.1. Increasing launch of combination drugs
5.1.3.2. Development of new imaging technologies and testing devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Urinary Tract Infection Testing Market, by Type
6.1. Introduction
6.2. Cystitis
6.3. Pyelonephritis
6.4. Urethritis
6.5. Vaginitis
7. Urinary Tract Infection Testing Market, by Test
7.1. Introduction
7.2. Cystoscopy Urinary Tract Infection Testing
7.3. Kidney & Bladder Ultrasound Urinary Tract Infection Testing
7.4. Laboratory Test
7.5. Non-Laboratory Test
7.6. Nuclear Scans Urinary Tract Infection Testing
7.7. Susceptibility Urinary Tract Infection Testing
7.8. Urinalysis Urinary Tract Infection Testing
7.9. Urine Culture Urinary Tract Infection Testing
7.10. Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing
8. Urinary Tract Infection Testing Market, by End-Use
8.1. Introduction
8.2. Accountable Care Organizations
8.3. General Practitioners
8.4. Hospital Emergency Departments
8.5. Hospital Laboratories
8.6. Reference Laboratories
8.7. Urgent Care
8.8. Urogynecologists
8.9. Urologists
9. Americas Urinary Tract Infection Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Urinary Tract Infection Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Urinary Tract Infection Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accelerate Diagnostics, Inc.
13.1.2. ACON Laboratories, Inc.
13.1.3. Beckman Coulter, Inc.
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. bioMérieux SA
13.1.6. Chungdo Pharm Co., Ltd.
13.1.7. F. Hoffmann-La Roche Ltd.
13.1.8. Genetworx, LLC
13.1.9. Module Innovations Pvt. Ltd.
13.1.10. QIAGEN GmbH
13.1.11. Randox Laboratories Ltd.
13.1.12. Siemens Healthcare GmbH
13.1.13. T2 Biosystems, Inc.
13.1.14. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
FIGURE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTOSCOPY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. URINARY TRACT INFECTION TESTING MARKET SIZE, BY KIDNEY & BLADDER ULTRASOUND URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NON-LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NUCLEAR SCANS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURE URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VOIDING CYSTOURETHROGRAM (VCUG) URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. URINARY TRACT INFECTION TESTING MARKET SIZE, BY ACCOUNTABLE CARE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. URINARY TRACT INFECTION TESTING MARKET SIZE, BY GENERAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL EMERGENCY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URGENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROGYNECOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 41. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 44. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 58. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 61. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 67. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 76. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 79. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 82. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 85. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 88. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 95. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 98. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 101. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 104. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 107. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 110. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 113. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 119. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 122. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 125. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 128. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 137. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 140. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 143. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 146. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 149. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 156. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 157. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 158. URINARY TRACT INFECTION TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Accelerate Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Chungdo Pharm Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genetworx, LLC
  • Module Innovations Pvt. Ltd.
  • QIAGEN GmbH
  • Randox Laboratories Ltd.
  • Siemens Healthcare GmbH
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 630.24 Million
Forecasted Market Value ( USD ) by 2030 $ 1167.86 Million
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 113 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 190 Pages
  • Global
From
Hospital-acquired Urinary Tract Infection Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hospital-acquired Urinary Tract Infection Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 114 Pages
  • Global
From
Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032 - Product Image

Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Hospital Acquired Urinary Tract Infection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Hospital Acquired Urinary Tract Infection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 98 Pages
  • Global
From

About the Urinary Tract Infection Testing Market

The Urinary Tract Infection (UTI) Testing market is a subset of the Urology and Nephrology industry. It is focused on the diagnosis and treatment of UTIs, which are caused by bacteria entering the urinary tract. UTI testing is used to identify the presence of bacteria in the urine, as well as to determine the type of bacteria present. Tests may include urine cultures, urine microscopy, and urine antigen tests. Treatment typically involves antibiotics, and in some cases, surgery. The UTI Testing market is driven by the increasing prevalence of UTIs, as well as the need for accurate diagnosis and treatment. The market is expected to grow in the coming years, as new technologies and treatments are developed. Some companies in the UTI Testing market include Siemens Healthineers, Abbott Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.